Zusammenfassung
In hellhäutigen Populationen aller Kontinente werden in ansteigender Zahl Aktinische Keratosen, auch solare Keratosen genannt, festgestellt. Diese Hautveränderungen, die einer In-situ-Karzinombildung entsprechen, finden sich vorwiegend in einer chronisch dem UV-Licht exponierten Haut. Woran Sie diese Hautveränderungen erkennen können, erfahren Sie hier.
Literatur
Armstrong BK, Kricker A. The epidemiology of UV induced skin cancer. J Photochem Photobiol B. 2001;63:8–18
Criscione VD, Weinstock MA, Naylor MF et al. Actinic keratoses natural history and risk of malignant transformation in the Veterans Affairs Tropical Tretinoin Chemoprevention Trial. Cancer. 2009;115:2523–30
de Rijke JM, Schouten LJ, Hillen HF et al. Cancer in the very elderly Dutch population. Cancer. 2000;89:1121–33
Diffey BL, Langtry JA. Skin cancer incidence and the ageing population. Br J Dermatol. 2005;153:679–80
Frost C, Williams G, Green A. High incidence and regression rates of solar keratoses in a queensland community. J Invest Dermatol. 2000;115:273–7
Holme SA, Malinovszky K, Roberts DL. Changing trends in nonmelanoma skin cancer in South Wales 1988-98. Br J Dermatol. 2000;143:1224–9
Lucas R, McMichael T, Smith W et al. Environmental Burden of Disease Series, No. 13. Solar Ultraviolet Radiation. Global Burden of Disease from Solar Ultraviolet Radiation. Geneva: World Health Organization, Public Health and the Environment, 2006
Salasche SJ. Epidemiology of actinic keratoses and squamous cell carcinoma. J Am Acad Dermatol. 2000;42:4–7
Memon AA, Tomenson JA, Bothwell J, Friedmann PS. Prevalence of solar damage and actinic keratosis in a Merseyside population. Br J Dermatol. 2000;142:1154–9
Heaphy MR Jr, Ackerman AB. The nature of solar keratosis: a critical review in historical perspective. J Am Acad Dermatol. 2000;43: 138–50
Stockfleth E, Sterry W, Carey-Yard M and Bichel J. Multicentre, open-label study using imiquimod 5% cream in one or two 4-week courses of treatment for multiple actinic keratoses on the head. Brit J Derm. 2007;157 (Suppl. 2):41–6
Schmitt J, Diepgen T, Bauer A. Occupational exposure to non-artificial UV-light and non-melanocytic skin cancer-a systematic review concerning a new occupational disease. J Deutsch Derm Gesell. 2010;8:250–64
Schwartz RA, Bridges TM, Butani AK, Ehrlich A. Actinic keratosis: an occupational and environmental disorder. J Eur Acad Dermatol Venereol. 2008;22:606–15
Dodson JM, DeSpain J, Hewett JE, Clark DP. Malignant potential of actinic keratoses and the controversy over treatment. A patient-oriented perspective. Arch Dermatol. 1991;127:1029–31
Werner RN, Sammain A, Erdmann R et al. The natural history of actinic keratosis: a systematic review. Br J Dermatol. 2013;169:502–18
Pritchett EN, Doyle A, Shaver ChM, Miller B, Abdelmalek M, Cusack CA, Malat GE, Chung CH L. Non-melanoma skin cancer in nonwhite organ transplant recipients. JAMA Dermatology. 2016;152:1348–53
Ashton KJ, Weinstein SR, Maguire DJ, Griffiths LR. Chromosomal aberrations in squamous cell carcinoma and solar keratoses revealed by comparative genomic hybridization. Arch Dermatol. 2003;139:876–82
Sorg O, Tran C, Saurat JH. Cutaneous vitamins A and E in the context of ultraviolet- or chemically-induced oxidative stress. Skin Pharmacol Appl Skin Physiol. 2001;14:363–72
Wiswedel I, Keilhoff G, Dörner L, Navarro A, Böckelmann R, Bonnekoh B, Gardemann A, GOLLNICK H. UVB irradiation-induced impairment of keratinocytes and adaptive responses to oxidative stress. Free Radical Res. 2007;41:1017–27
Biesalski H, Hemmes Ch, Hopfenmüller W, Schmid Ch, Gollnick H. Effects of controlled exposure of sunlight on plasma and skin levels of ß-carotene. Free Radic Res. 1996 24:215–24
Gollnick H, Hopfenmüller W, Hemmes Ch, Chun S, Schmid Ch, Sundermeier K, Biesalski H. Systemic beta carotene plus topical UV-sunscreen are an optimal protection against harmful effects of natural UV-sunlight: results of the Berlin-Eilath study. Eur J Dermatol. 1996;6:200–5
Jackson S, Storey A. E6 proteins from diverse cutaneous HPV types inhibit apoptosis in response to UV damage. Oncogene. 2000;19: 592–8
Stockfleth E, Meyer T, Benninghoff B, Salasche S, Papadopoulos L, Ulrich C, Christophers E. A randomized, double-blind, vehicle-controlled study to assess 5% imiquimod cream for the treatment of multiple actinic keratoses. Arch Dermatol 2002;138: 1498–50
McBride P, Neale R, Pandeya N, Green A. Sun-related factors, betapapillomavirus, and actinic keratoses: a prospective study. Arch Dermatol. 2007;143:862–8
Clydesdayle G, Dandle GW, Müller HK. Ultraviolet light induced injury: Immunological and inflammatory effects. Immunology and Cell Biology 2001;79:547–68
Ambach A, Bonnekoh B, Gollnick H. UVA radiation induces suppression of perforin-granule release from CD8hi + cytotoxic T lymphocytes ex vivo. J Invest Dermatol. 2004;123:237–9
Schwarz Th. UV-induzierte regulatorische T-Zellen. JDDG. 2005;3:507–10
Slaughter DP, Southwick HN, Smejkal W. Field cancerization in oral stratified squamous epithelium. Clinical implications of multicentric origin. Cancer. 1953;6:963–8
Braakhuis BJM, Tabor MP, Kummer JA, Leemans CR, Brakenhoff RH. A genetic explanation of Slaughter’s concept of field cancerization: Evidence and clinical implications. Cancer Res. 2003;63:1727–30
Anwar J, Wrone DA, Kimyai-Asadi A, Alam M. The development of actinic keratosis into invasive squamous cell carcinoma: evidence and evolving classification schemes. Clin Dermatol. 2004;22:189–96
Fuchs A, Marmur E. The kinetics of skin cancer: progression of actinic keratosis to squamous cell carcinoma. Dermatol Surg. 2007;33:1099–101
Guenthner ST, Hurwitz RM, Buckel LJ, Gray HR. Cutaneous squamous cell carcinomas consistently show histologic evidence of in situ changes: A clinicopathologic correlation. J Am Acad Dermatol 1999;41:443–8
Lober BA, Lober CW. Actinic keratosis is squamous cell carcinoma. South Med J. 2000;93:650–5
Peris K, Micantonio T, Piccolo D, Fargnoli MC. Dermoscopic features of actinic keratosis. J Dtsch Dermatol Ges. 2007;5:970–6
Zalaudek I, Kreusch J, Giacomel J, Ferrara G, Catricalà C, Argenziano G. How to diagnose nonpigmented skin tumors: a review of vascular structures seen with dermoscopy: part II. Nonmelanocytic skin tumors. J Am Acad Dermatol. 2010;63:377–86
Ulrich M, Maltusch A, Röwert-Huber J, González S, Sterry W, Stockfleth E, Astner S. Actinic keratoses: non-invasive diagnosis for field cancerisation. Br J Dermatol. 2007;156 (Suppl 3):13–7
Korde VR, Bonnema GT, Xu W, Krishnamurthy C, Ranger-Moore J, Saboda K, Slayton LD, Salasche SJ, Warneke JA, Alberts DS, Barton JK. Using optical coherence tomography to evaluate skin sun damage and precancer. Lasers Surg Med. 2007;39:687–95
Mogensen M, Jemec GB. Diagnosis of nonmelanoma skin cancer/keratinocyte carcinoma: a review of diagnostic accuracy of nonmelanoma skin cancer diagnostic tests and technologies. Dermatol Surg. 2007;33:1158–74
Göppner D, Mechow N, Liebscher J, Thiel E, Seewald G, Buchholz A, Gollnick H, Philipp CM, Schönborn K-H. Hochauflösende Zwei-Photonen-Bildgebung von H&E-Schnitten in der Dermatohistopathologie: eine Pilotstudie an Hauttumoren. Photonics & Lasers in Medicine. 2012;1:133–40
Yantsos VA, Conrad N, Zabawski E, Cockerell CJ. Incipient intraepidermal cutaneous squamous cell carcinoma: a proposal for reclassifying and grading solar (actinic) keratoses. Semin Cutan Med Surg. 1999;18:3–14
Kerl H, Garbe C, Cerroni L Wolff HH (Eds). Histopathologie der Haut. Springer Verlag 2001.
Ackerman AB. Solar keratosis is squamous cell carcinoma. Arch Dermatol 2003;139:1216–7
Glogau RG. The risk of progression to invasive disease. J Am Acad Dermatol. 2000;42:23–4
Schmitz L, Kahl P, Majores M, Bierhoff E, Stockfleth E, Dirschka T. Actinic keratosis: correlation between clinical and histological classification systems. JEADV 2016;30:1303-
Quaedvlieg PJ, Tirsi E, Thissen MR, Krekels GA. Actinic keratosis: how to differentiate the good from the bad ones? Eur J Dermatol. 2006;16:335–9
Röwert-Huber J, Patel MJ, Forschner T, Ulrich C, Eberle J, Kerl H, Sterry W, Stockfleth E. Actinic keratosis is an early in situ squamous cell carcinoma: a proposal for reclassification. Br J Dermatol. 2007;156(Suppl 3):8–12
Author information
Authors and Affiliations
Corresponding author
Additional information
This article is part of a supplement not sponsored by the industry.
INTERESSENKONFLIKT
Der Autor erklärt, dass er sich bei der Erstellung des Beitrages von keinen wirtschaftlichen Interessen leiten ließen. Er legt folgende potenzielle Interessenkonflikte offen: keine.
Der Verlag erklärt, dass die inhaltliche Qualität des Beitrags von zwei unabhängigen Gutachtern geprüft wurde. Werbung in dieser Zeitschriftenausgabe hat keinen Bezug zur CME-Fortbildung. Der Verlag garantiert, dass die CME-Fortbildung sowie die CME-Fragen frei sind von werblichen Aussagen und keinerlei Produktempfehlungen enthalten. Dies gilt insbesondere für Präparate, die zur Therapie des dargestellten Krankheitsbildes geeignet sind.
Rights and permissions
About this article
Cite this article
Gollnick, H.P.M. Die Früherkennung der Aktinischen Keratose. MMW - Fortschritte der Medizin 159 (Suppl 1), 57–63 (2017). https://doi.org/10.1007/s15006-017-9042-6
Published:
Issue Date:
DOI: https://doi.org/10.1007/s15006-017-9042-6